Ignite Creation Date:
2024-05-06 @ 10:09 AM
Last Modification Date:
2024-10-26 @ 12:25 PM
Study NCT ID:
NCT03174171
Status:
COMPLETED
Last Update Posted:
2019-01-09
First Post:
2017-05-24
Brief Title:
Open-label Study on Treatment of Primary Aldosteronism With Everolimus
Sponsor:
University Hospital Basel Switzerland
Organization:
University Hospital Basel Switzerland
Organization Data
Organization:
University Hospital Basel Switzerland
Class:
OTHER
Study ID:
EPA
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
University Hospital Basel Switzerland
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None